Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that’s used to treat pain, inflammation, and fever. It’s one of the most popular drugs in its class, yet there are still many questions surrounding dosage, side effects, and more. In this blog post, we’ll be exploring Meloxicam and all you need to know as a medical professional. From proper dosage information to potential side effects and contraindications, this guide will help you provide the best care for your patients who are on the drug or considering it as an option. Read on to learn more!
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and swelling. It is also used to reduce fever. Meloxicam works by blocking the production of substances that cause inflammation.
The recommended dosage of meloxicam is 7.5 mg/day, taken as a single dose. For patients who require a higher dose, the maximum recommended dose is 15 mg/day. Meloxicam should be taken with food or milk to reduce stomach upset. The usual adult dosage of meloxicam for arthritis is 7.5 mg once daily. Some patients may require a higher dose of 15 mg once daily. The recommended starting dose for children is 0.125 mg/kg once daily, up to a maximum of 7.5 mg per day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
If you are considering starting a patient on meloxicam, there are some important things to keep in mind regarding safety and side effects. Here is a brief guide to help you get started: Important Safety Information: Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) and should be used with caution in patients with a history of NSAID-related gastric ulcers or gastrointestinal bleeding. Meloxicam may also increase the risk of serious cardiovascular events, such as heart attack or stroke. Therefore, it is important to weigh the potential risks and benefits of meloxicam therapy before starting a patient on this medication.
The most common side effects associated with meloxicam include headache, dizziness, abdominal pain, constipation, diarrhea, nausea, and vomiting. Less common side effects include rashes and allergic reactions. Common side effects of meloxicam include: nausea,vomiting upset stomach, diarrhea, constipation, dizziness. Less common side effects include: rashes, hives, itching, difficulty breathing or swallowing, wheezing swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs, hoarseness, joint pain, back pain, anxiety, blurred vision
There are a few things to keep in mind when monitoring patients taking meloxicam. First, it's important to monitor for signs of gastrointestinal bleeding. Meloxicam can increase the risk of GI bleeding, so it's important to watch for any signs of blood in the stool or vomit, or black, tarry stools. Second, it's important to monitor kidney function in patients taking meloxicam. This drug can cause fluid retention and worsen existing kidney problems. Therefore, it's important to check creatinine levels and urine output in patients taking this medication. Finally, it's important to monitor for signs of allergic reactions. Meloxicam can cause rashes, hives, itching, and difficulty breathing.
Meloxicam is a commonly prescribed nonsteroidal anti-inflammatory drug that has many uses and benefits. It can be an effective analgesic for moderate to severe pain relief and is also used to treat other medical conditions such as osteoarthritis, rheumatoid arthritis, and gout. As with any medication, it’s important to discuss the risks and benefits of using meloxicam with your patients before prescribing it. We hope that this guide has given you all the information you need to ensure that your patients are safe when taking this medication.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation